Restricted to use by Infectious Diseases prescribers for the FDA approved indication: in patients ≥18 years of age for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Acinetobacter baumannii-calcoaceticuscomplex.
Antimicrobial Management Team consult is required.
Add Formweb to your mobile device
Restricted to use by Infectious Diseases prescribers for the FDA approved indication: in patients ≥18 years of age for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex.
Antimicrobial Management Team consult is required.
Reviewed: October 2023
Sulbactam/Durlobactam (Xacduro)